Agenda Clinical Hematology & Oncology 2018

Saturday, February 17, 2018

Saturday, February 17, 2018

Topic: Nonmalignant Hematology


7 a.m.

Registration, Breakfast & View Exhibits


7:50 a.m.

Welcome and Introduction


8 a.m.

ITP Update for 2018

John Kelton, MD


8:45 a.m.

‘Mind the Gap’: Timing Issues in Autoimmune HIT and Symmetrical Peripheral Gangrene Complicating DIC

Theodore Warkentin, MD


9:30 a.m.

Break & View Exhibits


10 a.m.

Sickle Cell Disease and Other Hemoglobinopathies: 2018 Update

Kathryn Hassell, MD


10:45 a.m.

Hormones and Thrombosis: Everything the Hematologist Wants to Know

Stephan Moll, MD


11:30 a.m.

Lessons Learned from Clinical Practice from Having Been an Expert Witness in Thrombosis & Hemostasis Law Suits

Craig Kitchens, MD


12:15 p.m.

Lunch


1:15 p.m.

Radiological Pitfalls Relevant for the Practicing Hem-Onc Physician

Katherine Birchard, MD


2 p.m.

Oncology Drugs Causing Bleeding or Clotting

David Garcia, MD


2:45 p.m.

Myelofibrosis: 2018 Review and Update

Brandi Reeves, MD


3:30 p.m.

Break & View Exhibits


4 p.m.

Workshops


Less Common Thromboses

Stephan Moll, MD


Syndromes of DIC

Theodore Warkentin, MD


Bleeding Disorders Not Due to Hemostatic Failure

Craig Kitchens, MD


Diagnosis & Management of Plasma Cell Disorders

Morie Gertz, MD


Perplexing Patients with Thrombocytopenia

John Kelton, MD


5 p.m.

Adjourn, Welcome & Networking Reception

Sunday, February 18, 2018

Sunday, February 18, 2018

Topic: Malignant Hematology


7 a.m.

Breakfast & View Exhibits


8 a.m.

Novel Strategies in Acute Leukemia of Relevance to Clinical Practice

Hagop Kantarjain, MD


8:45 a.m.

Complicated Clinical Scenarios in Myeloma

Morie Gertz, MD


9:30 a.m.

Break & View Exhibits


10 a.m.

CAR-T Therapy for Acute Leukemia

Stephen Schuster, MD


10:45 a.m.

Current Approaches to Mantle Cell Lymphoma: Diagnosis, Prognosis, and Therapies

James Mason, MD


11:30 a.m.

Immunotherapy in Myeloid Malignancies

Eunice Wang, MD


12:15 p.m.

Lunch


1:15 p.m.

The Oncology Care Model: Medicare’s Alternative Payment Model and the Future of Bundled Payments in Oncology

Stephen Grubbs, MD


2 p.m.

CLL: Ibrutinib Alone or Ibrutinib “Plus”?

Marin Xavier, MD


2:45 p.m.

Evolution of Targeted Therapies for Myeloproliferative Neoplasms

Brandi Reeves, MD


3:30 p.m.

Breakfast & View Exhibits


4 p.m.

Workshops (Repeat from Saturday)


Less Common Thromboses

Stephan Moll, MD


Syndromes of DIC

Theodore Warkentin, MD


Bleeding Disorders Not Due to Hemostatic Failure

Craig Kitchens, MD


Diagnosis & Management of Plasma Cell Disorders

Morie Gertz, MD


5 p.m.

Adjourn

Monday, February 19, 2018

Monday, February 19, 2018

Topic: Updates in Oncology


7 a.m.

Breakfast & View Exhibits


8 a.m.

CardioOncology, the Role of the Cardiologist in Modern Oncologic Care

Jean-Bernard Durand, MD


8:45 a.m.

Prostate Cancer 2018

David Quinn, MD


9:30 a.m.

Break & View Exhibits


10 a.m.

Upfront Management of Operable Lung Cancer

Antoinette Wozniak, MD


10:45 a.m.

Individualizing Therapy and Improving Survival in Colorectal Cancer

Cathy Eng, MD


11:30 a.m.

Immunotherapy in Upper Gastrointestinal Malignancies: Hepatocellular Carcinoma

Anthony B. El-Khoueiry, MD


12:15 p.m.

Lunch


1:15 p.m.

Incorporating Precision Medicine Into Your Practice: How, Why, and When?

Edward Kim, MD


2 p.m.

Operable Melanoma: Updates on Screening, Prognostication, and Adjuvant-Neoadjuvant Therapies

Ahmad A. Tarhini, MD


2:45 p.m.

Biomarkers for Immunotherapy: An Illusion or Reality?

Leona Horn, MD


3:30 p.m.

Break & View Exhibits


4 p.m.

Important Issues Facing Oncologists, and What You Can Do

Barbra McAneny, MD, President Elect—American Medical Association


4:45 p.m.

Targeted Therapy for Head and Neck Cancer

Joshua Bauml, MD


5:30 p.m. 

Adjourn

Tuesday, February 20, 2018

Tuesday, February 20, 2018

Topic: Innovations in Breast Cancer


7 a.m.

Breakfast


7:30 a.m.

Lifestyle Interventions to Improve Cardiorespiratory Fitness and Reduce Breast Cancer Occurrence

Kathryn Elizabeth Hudson, MD


8:15 a.m.

The WISDOM Study: Screening for Breast Cancer

Allison Stover


9 a.m.

Break


9:15 a.m.

Management of Heterogeneous Breast Cancers

Heather McArthur, MD, MPH


10 a.m.

Optimizing Neoadjuvant/Adjuvant Treatment Options in Patients with HER2 Amplification

Sara Hurvitz, MD


10:45 a.m.

The Triple Negative Conundrum

Joyce O’Shaughnessy, MD


11:30 a.m.

Final Adjournment


Topics, times and speakers are subject to change